hydrogen sulfide has been researched along with Atheroma in 9 studies
Hydrogen Sulfide: A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed)
hydrogen sulfide : A sulfur hydride consisting of a single sulfur atom bonded to two hydrogen atoms. A highly poisonous, flammable gas with a characteristic odour of rotten eggs, it is often produced by bacterial decomposition of organic matter in the absence of oxygen.
thiol : An organosulfur compound in which a thiol group, -SH, is attached to a carbon atom of any aliphatic or aromatic moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydrogen sulfide, as a novel gaseous mediator, has been suggested to play a key role in atherogenesis." | 7.78 | Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression. ( Gu, T; Guo, C; Wang, C; Wang, L; Wu, D; Zhang, A; Zhang, H, 2012) |
| "Hydrogen sulfide (H(2)S) is a novel gaseous mediator that plays important roles in atherosclerosis." | 7.78 | Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice. ( Fan, Y; Gu, T; Guo, C; Sparatore, A; Wang, C; Wu, D; Zhang, A; Zhang, H, 2012) |
| "Hydrogen sulfide (H2S) is an important gaseous signaling molecule that functions in physiological and pathological conditions, such as atherosclerosis." | 3.80 | Anti-atherogenic effect of hydrogen sulfide by over-expression of cystathionine gamma-lyase (CSE) gene. ( Cheung, SH; Kwok, WK; Lau, JY; To, KF, 2014) |
| "Hydrogen sulfide, as a novel gaseous mediator, has been suggested to play a key role in atherogenesis." | 3.78 | Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression. ( Gu, T; Guo, C; Wang, C; Wang, L; Wu, D; Zhang, A; Zhang, H, 2012) |
| "Hydrogen sulfide (H(2)S) is a novel gaseous mediator that plays important roles in atherosclerosis." | 3.78 | Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice. ( Fan, Y; Gu, T; Guo, C; Sparatore, A; Wang, C; Wu, D; Zhang, A; Zhang, H, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z | 1 |
| Ouyang, C | 1 |
| Zhang, H | 3 |
| Gu, Y | 1 |
| Deng, Y | 1 |
| Du, C | 1 |
| Cui, C | 1 |
| Li, S | 1 |
| Wang, W | 1 |
| Kong, W | 1 |
| Chen, J | 1 |
| Cai, J | 1 |
| Geng, B | 1 |
| Gui, DD | 1 |
| Luo, W | 1 |
| Yan, BJ | 1 |
| Ren, Z | 1 |
| Tang, ZH | 1 |
| Liu, LS | 1 |
| Zhang, JF | 1 |
| Jiang, ZS | 1 |
| Bibli, SI | 1 |
| Hu, J | 1 |
| Sigala, F | 2 |
| Wittig, I | 1 |
| Heidler, J | 1 |
| Zukunft, S | 1 |
| Tsilimigras, DI | 1 |
| Randriamboavonjy, V | 1 |
| Wittig, J | 1 |
| Kojonazarov, B | 1 |
| Schürmann, C | 1 |
| Siragusa, M | 1 |
| Siuda, D | 1 |
| Luck, B | 1 |
| Abdel Malik, R | 1 |
| Filis, KA | 1 |
| Zografos, G | 2 |
| Chen, C | 1 |
| Wang, DW | 1 |
| Pfeilschifter, J | 1 |
| Brandes, RP | 1 |
| Szabo, C | 1 |
| Papapetropoulos, A | 2 |
| Fleming, I | 1 |
| Cheung, SH | 1 |
| Kwok, WK | 1 |
| To, KF | 1 |
| Lau, JY | 1 |
| Li, D | 1 |
| Xiong, Q | 1 |
| Peng, J | 1 |
| Hu, B | 1 |
| Li, W | 1 |
| Zhu, Y | 1 |
| Shen, X | 1 |
| Efentakis, P | 1 |
| Karageorgiadi, D | 1 |
| Filis, K | 1 |
| Zampas, P | 1 |
| Iliodromitis, EK | 1 |
| Andreadou, I | 1 |
| Guo, C | 2 |
| Wu, D | 2 |
| Zhang, A | 2 |
| Gu, T | 2 |
| Wang, L | 1 |
| Wang, C | 2 |
| Zhou, K | 1 |
| Gao, Q | 1 |
| Zheng, S | 1 |
| Pan, S | 1 |
| Li, P | 1 |
| Suo, K | 1 |
| Simoncini, T | 1 |
| Wang, T | 1 |
| Fu, X | 1 |
| Fan, Y | 1 |
| Sparatore, A | 1 |
1 review available for hydrogen sulfide and Atheroma
| Article | Year |
|---|---|
Effects of gut microbiota on atherosclerosis through hydrogen sulfide.
Topics: Animals; Arteries; Atherosclerosis; Bacteria; Gasotransmitters; Gastrointestinal Microbiome; Humans; | 2021 |
8 other studies available for hydrogen sulfide and Atheroma
| Article | Year |
|---|---|
Vascular smooth muscle cell-derived hydrogen sulfide promotes atherosclerotic plaque stability via TFEB (transcription factor EB)-mediated autophagy.
Topics: Atherosclerosis; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Biomarkers; | 2022 |
Cystathionine γ Lyase Sulfhydrates the RNA Binding Protein Human Antigen R to Preserve Endothelial Cell Function and Delay Atherogenesis.
Topics: Aged; Aged, 80 and over; Animals; Atherosclerosis; Carotid Arteries; Carotid Artery Diseases; Cathep | 2019 |
Anti-atherogenic effect of hydrogen sulfide by over-expression of cystathionine gamma-lyase (CSE) gene.
Topics: Adiponectin; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Blood Pressure; Body Weight; Cystat | 2014 |
Hydrogen Sulfide Up-Regulates the Expression of ATP-Binding Cassette Transporter A1 via Promoting Nuclear Translocation of PPARα.
Topics: Animals; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins E; ATP Binding Cassette Transporte | 2016 |
Reciprocal regulation of eNOS, H
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; F | 2017 |
Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression.
Topics: Animals; Aorta; Atherosclerosis; Catalysis; Chemokine CX3CL1; Chemotaxis; CX3C Chemokine Receptor 1; | 2012 |
17β-estradiol induces vasorelaxation by stimulating endothelial hydrogen sulfide release.
Topics: Acetylcholine; Alkynes; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Cyclic GMP-Dependent Pro | 2013 |
Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice.
Topics: Animals; Apolipoproteins E; Aspirin; Atherosclerosis; Brachiocephalic Trunk; Cell Line; Chemotaxis; | 2012 |